A Radio Free Europe/Radio Liberty article looks at the consequences of restrictive stem cell legislation in the US. The ability of the US research community to move rapidly towards well-developed and effective regenerative medicine is being squandered. Investors are scared away by political threats to fundamental technologies like therapeutic cloning. Since most research is privately funded, the rate of advance towards cures for age-related conditions has been slow. The consequences of delay are terrible: those who are trying so hard to block regenerative medicine will be responsible for suffering and death on a vast scale.